Dr. Noor Hisham: AstraZeneca and CoronaVac were granted conditional approval as Covid-19 booster

WhatsAppWhatsAppFacebookFacebookTwitterTwitterPinterestPinterestRedditRedditGmailGmailShareShare

MalaysiaMalaysiaMalaysia – The 366th Drug Control Authority (DCA) has given their permission to provide conditional clearance for the use of both the AstraZeneca and CoronaVac vaccines as a Covid-19 booster dosage to those who are aged 18 and above who have already had a main series of immunization from the same kind of vaccine (homologous).

The booster dosage for the AstraZeneca vaccine would be administered six months after the initial two shots, according to Tan Sri Dr Noor Hisham Abdullah, the director-general of health.

Meanwhile for CoronaVac, after the initial two doses of the vaccine have been given, a booster dose would be administered three to six months later.

The health director-general also added that the Covid-19 Immunisation Task Force-Booster (CITF-B) will choose who receives the booster dose for both vaccinations, and it will be disclosed on a regular basis.

DCA also granted conditional clearance registration for AstraZeneca Solution for Injection vaccine from the third producer, SK Bioscience Co., during the meeting held recently, according to Dr. Noor Hisham. The vaccine’s registration is held by AstraZeneca Sdn. Ltd. of South Korea. Bhd.

Related Posts

He stated that the DCA had already provided conditional registration approval to the first producer, AstraZeneca Nijmegen B.V. of the Netherlands, and Siam Bioscience Co., Ltd. of Thailand.

He explained that conditional registration approval necessitates data on the vaccine’s quality, safety, and efficacy, which must be monitored and assessed on a regular basis based on the most recent information.

According to Dr. Noor Hisham, it’s also to guarantee that the vaccine’s advantages outweighed the risk. He stated that the Health Ministry (MOH) has always been working to improve accessibility to Covid-19 vaccines in Malaysia by making sure that it is examined by the National Pharmaceutical Regulatory Agency (NPRA) for quality, safety, and efficacy before being authorized for use by DCA.

Katherine S

1/4 German, 3/4 Malaysian. I write, follow and monitor closely political news happening in Malaysia, and other happening news in the ASEAN region. Newswriter for the best ASEAN news website - The Asian Affairs.

Recent Posts

Trump Dismisses France’s Palestine Recognition Plan as Meaningless

US President Donald Trump has sharply condemned the move by his French counterpart, Emmanuel Macron, to recognize Palestine to be…

July 26, 2025

Upcoming Fireworks Festival Display on 26th July 2025 in Japan

The firework festival that is celebrated across Japan traces its roots back to the 18th century of the Kyoho famine.…

July 25, 2025

Cambodia Accuses Thailand of Rejecting ASEAN Ceasefire Deal Over Border Conflict

This escalation of a border dispute between Thailand and Cambodia has gained momentum and is becoming a serious threat, as…

July 25, 2025

India’s Splendid All-Rounder Veda Krishnamurthy Bids an Emotional Farewell to Her Professional Cricket

Sports is one such profession where an individual announces their retirement even before their forties. It might be a pricking…

July 25, 2025

‘Dreamy Day’ Mun Ka Young Locks the Date of Her Debut Fan Meet in Asia

Moon Ga Young, anchored herself as a charming, versatile actress with a strong screen presence in the South Korean entertainment…

July 25, 2025

AFF U-23 2025 Championship: Vietnam U23 Landed in Finals! Who is the Counter Part?

Hope, courage and a wave of positivity is circled around the stadium within the team and among the fans who…

July 25, 2025